Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 1-20 of 152

Title Anticipated publication date Referral date Process
Kidney transplantation (rejection) - everolimus [ID117] TBC Jul 2009
Acute coronary syndrome - prasugrel with PCI (review TA182) [ID 648] Aug 2014 MTA
Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142) [ID541] Aug 2014 MTA
Ankylosing spondylitis and axial spondyloarthritis (non-radiographic) - adalimumab, etanercept infliximab and golimumab (inc rev TA143 and TA233) Jan 2015 MTA
Arrythmias - ICDs & Heart failure - cardiac resynchronisation [ID481] Jun 2014 MTA
Atrial fibrillation - ximelagatran [ID376] TBC Oct 2000 MTA
Bradycardia - dual chamber pacemakers (review of TA88) [ID697] Feb 2015 MTA
Breast cancer (early) - intrabeam radiotherapy system [ID618] Nov 2014 MTA
Breast cancer (metastatic) -trastuzumab (as monotherapy and in combination with a taxane) [ID345] Oct 2011 MTA
Breast cancer - intensity modulated radiotherapy [ID16] TBC Mar 2008 MTA
Chronic iron overload (in people with thalassaemia) - desferrioxamine, deferiprone and deferasirox [ID350] TBC Jul 2010 MTA
Clinically isolated syndrome - beta interferons and glatiramer acetate [ID109] TBC Jul 2009 MTA
Dementia (non-Alzheimer) - new pharmaceutical treatments [ID380] TBC Mar 2003 MTA
Diabetic foot ulcers - new treatments [ID381] TBC Mar 2003 MTA
Dupuytren's contracture - collagenase clostridium histolyticum [ID621] Jan 2015 MTA
Falls - faller's clinics [ID103] TBC Oct 2000 MTA
Head and neck cancer - intensity modulated radiotherapy [ID15] TBC Mar 2008 MTA
Hepatitis B (adults) - entecavir and tenofovir disoproxil fumarate [ID111] TBC MTA
Knee cartilage defects - autologous chondrocyte implantation [ID686] Jul 2015 Oct 2013 MTA
Lung cancer (non-small cell) - erlotinib & gefitinib (post chemotherapy) (rev TA162, TA175) [ID620] Jun 2014 MTA

This page was last updated: 16 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.